460 related articles for article (PubMed ID: 22940490)
1. Ultrastaging of para-aortic lymph nodes in stage IIIC1 endometrial cancer: a preliminary report.
Todo Y; Suzuki Y; Azuma M; Hatanaka Y; Konno Y; Watari H; Kato H; Matsuno Y; Yamashiro K; Sakuragi N
Gynecol Oncol; 2012 Dec; 127(3):532-7. PubMed ID: 22940490
[TBL] [Abstract][Full Text] [Related]
2. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.
Mariani A; Dowdy SC; Cliby WA; Haddock MG; Keeney GL; Lesnick TG; Podratz KC
Gynecol Oncol; 2006 May; 101(2):200-8. PubMed ID: 16510174
[TBL] [Abstract][Full Text] [Related]
4. The role of para-aortic lymphadenectomy in stage IIIC endometrial cancer: A single-institute study.
Kikuchi A; Yanase T; Sasagawa M; Honma S
J Obstet Gynaecol; 2017 May; 37(4):510-513. PubMed ID: 28421906
[TBL] [Abstract][Full Text] [Related]
5. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.
Fotopoulou C; Savvatis K; Kraetschell R; Schefold JC; Lichtenegger W; Sehouli J
Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):199-203. PubMed ID: 20096987
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis on the lymph nodes metastasis characters and their relation with the prognosis of the endometrial carcinoma patients].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):435-40. PubMed ID: 21781585
[TBL] [Abstract][Full Text] [Related]
7. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
[TBL] [Abstract][Full Text] [Related]
8. Can we omit para-aorta lymph node dissection in endometrial cancer?
Tanaka H; Sato H; Miura H; Sato N; Fujimoto T; Konishi Y; Takahashi O; Tanaka T
Jpn J Clin Oncol; 2006 Sep; 36(9):578-81. PubMed ID: 16870694
[TBL] [Abstract][Full Text] [Related]
9. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer.
Yabushita H; Shimazu M; Yamada H; Sawaguchi K; Noguchi M; Nakanishi M; Kawai M
Gynecol Oncol; 2001 Feb; 80(2):139-44. PubMed ID: 11161851
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of gross myometrial invasion with endometrial cancer.
Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
[TBL] [Abstract][Full Text] [Related]
11. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancer.
Polterauer S; Khalil S; Zivanovic O; Abu-Rustum NR; Hofstetter G; Concin N; Grimm C; Reinthaller A; Barakat RR; Leitao MM
Obstet Gynecol; 2012 Jun; 119(6):1210-8. PubMed ID: 22617586
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic spread among women with primary peritoneal carcinoma.
Eltabbakh GH; Mount SL
J Surg Oncol; 2002 Nov; 81(3):126-31. PubMed ID: 12407724
[TBL] [Abstract][Full Text] [Related]
14. Pelvic and para-aortic lymphadenectomy for surgical staging of high-risk endometrioid adenocarcinoma of the endometrium.
Larson DM; Johnson KK
Gynecol Oncol; 1993 Dec; 51(3):345-8. PubMed ID: 8112643
[TBL] [Abstract][Full Text] [Related]
15. Endometrial cancer metastatic to infrarenal aortic lymph nodes unrecognized during laparoscopic inframesenteric aortic lymph node dissection.
Eitan R; Abu-Rustum NR; Walker JL; Barakat RR
Gynecol Oncol; 2004 Apr; 93(1):260-2. PubMed ID: 15047248
[TBL] [Abstract][Full Text] [Related]
16. Distribution of lymph node metastasis sites in endometrial cancer undergoing systematic pelvic and para-aortic lymphadenectomy: a proposal of optimal lymphadenectomy for future clinical trials.
Odagiri T; Watari H; Kato T; Mitamura T; Hosaka M; Sudo S; Takeda M; Kobayashi N; Dong P; Todo Y; Kudo M; Sakuragi N
Ann Surg Oncol; 2014 Aug; 21(8):2755-61. PubMed ID: 24705578
[TBL] [Abstract][Full Text] [Related]
17. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.
Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K
Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.
Cragun JM; Havrilesky LJ; Calingaert B; Synan I; Secord AA; Soper JT; Clarke-Pearson DL; Berchuck A
J Clin Oncol; 2005 Jun; 23(16):3668-75. PubMed ID: 15738538
[TBL] [Abstract][Full Text] [Related]
19. Incidence of micrometastases in histologically negative para-aortic lymph nodes in advanced cervical cancer patients.
MartÃnez A; Mery E; Ferron G; Querleu D
Gynecol Oncol; 2010 Oct; 119(1):76-80. PubMed ID: 20667586
[TBL] [Abstract][Full Text] [Related]
20. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
